Organic Recyclin - Organic Recyclin
Financial Performance
Revenue Growth by Segment
Consolidated revenue from operations grew 59.27% YoY from INR 275 million in FY24 to INR 438 million in FY25. The company operates across EPC, Products, Output Monetization, and Licensing segments, achieving a 37% CAGR from FY21 to FY25.
Geographic Revenue Split
The company executes projects PAN India with key operations in Delhi, Kolkata, Kerala, and Maharashtra. Specific percentage split per region is not disclosed, but nationwide execution is a primary driver.
Profitability Margins
Net profitability saw a massive turnaround with PAT increasing 102% YoY to INR 157 million in FY25. PAT margin improved from -29% in FY24 to 32% in FY25, driven by higher-margin EPC contracts and operational efficiencies.
EBITDA Margin
EBITDA margin stood at 36% in FY25, a slight decrease from 38% in FY24, despite EBITDA absolute value growing 53.4% YoY to INR 158 million. The margin expansion from 1% in FY21 to 36% in FY25 reflects the shift toward proprietary technology commercialization.
Capital Expenditure
The company is investing in a backward integration initiative involving the acquisition of a fabrication facility and the Solapur plant upgrade. Total assets increased from INR 1,350 million to INR 1,936 million in FY25, representing a 43.4% increase in the asset base.
Credit Rating & Borrowing
Long-term borrowings stood at INR 350 million in FY25. Debt/Equity ratio improved from 7.3x in FY24 to 5.0x in FY25 due to a significant increase in shareholder funds from INR 816 million to INR 1,354 million.
Operational Drivers
Raw Materials
Key feedstocks include Municipal Solid Waste (MSW), Organic Waste, and Napier Grass (cultivated over 150 acres). Feedstock aggregation and seasonal availability are cited as critical operational bottlenecks.
Import Sources
Feedstock is primarily sourced locally within India from municipal corporations and agricultural clusters in states like Maharashtra (Solapur) and Uttar Pradesh (Varanasi).
Key Suppliers
Suppliers include municipal bodies for MSW and local farmers for Napier grass. The company also partnered with Indian Oil Corporation Ltd (IOCL) for technology commercialization.
Capacity Expansion
Current initiatives include the Solapur plant upgrade for CBG offtake and the cultivation of Napier grass over 150 acres to ensure a stable supply of green energy feedstock.
Raw Material Costs
Total expenses excluding depreciation and finance costs rose 62.8% to INR 280 million in FY25. Raw material costs are managed through backward integration into fabrication and feedstock cultivation.
Manufacturing Efficiency
The company utilizes patented technologies like DRYAD and Marut Drum to improve organic fraction recovery and anaerobic digestion efficiency.
Logistics & Distribution
Distribution is supported by the SATAT scheme and long-term offtake contracts with PSUs like IOCL, BPCL, and HPCL for CBG.
Strategic Growth
Expected Growth Rate
37%
Growth Strategy
Growth will be driven by scaling the biomedical waste vertical (market expected to reach USD 3.45 billion by 2033), commercializing R&D innovations like the BIO-CCU platform, and expanding high-margin CleanTech EPC projects nationwide.
Products & Services
Compressed Bio-Gas (CBG), Bio-fertilizers, Biochar, Refuse Derived Fuel (RDF), and specialized advisory services in environmental strategy.
Brand Portfolio
DRYAD (Anaerobic Digestion), Marut Drum (Organic Recovery), LIPH-AD, INV-CO, EW-CO, Sanjeevak, and Alpha Carbon.
New Products/Services
Indiaβs first pilot-scale BIO-CCU platform for CO2 valorization and decentralized modular biogas systems. Expected to contribute to revenue through technology licensing.
Market Expansion
Expansion into sustainable chemicals and catalyst distribution to support eligibility for larger project bids and diversify revenue.
Market Share & Ranking
Prominent homegrown CleanTech company; the CBG sector has <1% installed capacity vs potential, indicating massive headroom.
Strategic Alliances
Collaborations with IIT Bombay, IIT Kharagpur, AGH University Poland, and University of Birmingham for deep-tech R&D.
External Factors
Industry Trends
The CBG sector is a national priority with a production potential of 62 MMT annually. The biomedical waste market is growing at 10% CAGR, driven by stricter 2016 regulatory rules.
Competitive Landscape
Positioned as a full-stack EPC provider in a fragmented market, competing with both local waste management firms and international technology providers.
Competitive Moat
Moat is built on 2 granted patents and 5+ proprietary technologies (DRYAD, Marut Drum). Sustainability is high due to the high technical barrier to entry in anaerobic digestion.
Macro Economic Sensitivity
Highly sensitive to government policy (SATAT scheme, Swachh Bharat Mission) and blending obligations (1-5% CBG blending in CGD networks by FY29).
Consumer Behavior
Shift toward circular economy and institutional adoption of compliant treatment technologies (autoclaving, microwave sterilization) is driving demand.
Geopolitical Risks
Minimal direct impact as feedstocks and customers are domestic, though global CleanTech trends influence R&D direction.
Regulatory & Governance
Industry Regulations
Operations are governed by the Companies Act 2013 and SEBI (LODR) Regulations 2015. Mandatory 1-5% CBG blending obligation by FY29 is a key regulatory tailwind.
Environmental Compliance
Fully compliant with Biomedical Waste Management Rules 2016 and Swachh Bharat Mission guidelines.
Taxation Policy Impact
The company faces tax structure ambiguity regarding GST vs VAT in CGD-CBG synchronization.
Legal Contingencies
No proceedings initiated or pending for Benami property. Directors are not disqualified under Section 164(2) of the Companies Act.
Risk Analysis
Key Uncertainties
Policy execution vs. ground realities and feedstock aggregation are the primary risks that could impact project timelines by 15-20%.
Geographic Concentration Risk
Revenue is concentrated in India, specifically in urban municipal clusters.
Third Party Dependencies
High dependency on municipal corporations for MSW feedstock supply and PSU oil companies for CBG offtake.
Technology Obsolescence Risk
Mitigated by continuous R&D and partnerships with IITs to develop next-gen carbon capture and valorization technologies.
Credit & Counterparty Risk
Trade receivables stood at INR 365 million in FY25. Receivables quality is generally high as clients are primarily government bodies and PSUs.